Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study
Kim et al., Journal of Korean Medical Science, doi:10.3346/jkms.2023.38.e99
https://c19early.org/kim11ppi.html